Cancer Research UK logo.

Test

SearchDonate
  • Search

A trial looking at lowering the risk of hearing loss after cisplatin chemotherapy in children or young people with hepatoblastoma (SIOPEL 6)

Overview

Cancer types:

Children's cancers

Status:

Results

Phase:

Phase 3

Details

This trial was done to find out if sodium thiosulphate can reduce high frequency hearing loss, which can be a side effect of cisplatin chemotherapy. It was for children and young people up to the age of 18 with hepatoblastoma that had not spread to another part of the body.

The trial was supported by Cancer Research UK.

Recruitment start: 15 December 2007

Recruitment end: 1 December 2014

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr M. Ronghe

Supported by

Cancer Research UK

Cancer Research UK Children's Cancer Trials Team

University of Birmingham

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/07/023.

Last reviewed: 02 Aug 2018

CRUK internal database number: 1107

Help and support